Acutus Medical, Inc. (AFIB)
USD 0.04
(-12.0%)
USD 0.04
(-12.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -63.6 Million | -85.03 Million | -99.68 Million | -85.16 Million | -55.98 Million | -33.78 Million |
| Net Income | -11.92 Million | -39.61 Million | -117.68 Million | -101.98 Million | -97.03 Million | -47.9 Million |
| Depreciation & Amortization | 874 Thousand | 7.12 Million | 6.89 Million | 3.9 Million | 3.16 Million | 2.12 Million |
| Deferred income taxes | 733 Thousand | - | 1.3 Million | 6.03 Million | 3.99 Million | 4.19 Million |
| Stock-based compensation | 3.03 Million | 3.4 Million | 13.75 Million | 12.1 Million | 2.99 Million | 2.07 Million |
| Change in working capital | 916 Thousand | -1.6 Million | -3.78 Million | -6.09 Million | -2.18 Million | 1.49 Million |
| Other non-cash items | -57.24 Million | -60.33 Million | -160 Thousand | 864 Thousand | 33.07 Million | 4.24 Million |
| Investing Cash Flow | 58.55 Million | 104.75 Million | 19.06 Million | -63.82 Million | -70.43 Million | -4.74 Million |
| Investments in PPE | -219 Thousand | -3.98 Million | -9.97 Million | -11.22 Million | -13.39 Million | -2.03 Million |
| Acquisitions | 17 Million | 70 Million | -29.03 Million | 52.59 Million | -3 Million | - |
| Investment purchases | -39.76 Million | -54.5 Million | -87.25 Million | -114.69 Million | -68.73 Million | -14.3 Million |
| Sales/Maturities of investments | 82.75 Million | 93.24 Million | 116.29 Million | 62.09 Million | 14.7 Million | 11.6 Million |
| Other Investing Activities | -1.21 Million | -3.75 Million | 29.03 Million | -52.59 Million | -10 Million | -2.7 Million |
| Financing Cash Flow | -2.17 Million | -12.11 Million | 79.56 Million | 164.43 Million | 126.33 Million | 37.41 Million |
| Debt repayment | - | -45.61 Million | - | - | -15 Million | -600 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -111 Thousand | -111 Thousand | - | - | - | - |
| Common Stock Issuance | 29 Thousand | 67 Thousand | 83.22 Million | 166.28 Million | 66.67 Million | 348 Thousand |
| Other Financing Activities | -2.2 Million | 33.54 Million | 79.56 Million | -1.85 Million | 74.66 Million | 38.01 Million |
| Accounts receivables | -1.07 Million | -452 Thousand | -1.47 Million | -1.89 Million | -96 Thousand | 26 Thousand |
| Accounts payables | 288 Thousand | -2.85 Million | -871 Thousand | 2.28 Million | 2.11 Million | 18 Thousand |
| Inventory | -2.48 Million | 3.08 Million | -3.87 Million | -3.89 Million | -5.42 Million | 523 Thousand |
| Other working capital | 4.18 Million | -1.38 Million | 2.42 Million | -2.59 Million | 1.22 Million | 929 Thousand |
| Cash at beginning of period | 31.34 Million | 24.22 Million | 25.38 Million | 9.6 Million | 9.77 Million | 10.92 Million |
| Cash at end of period | 26.2 Million | 31.34 Million | 24.22 Million | 25.38 Million | 9.6 Million | 9.77 Million |
| Capital Expenditure | -219 Thousand | -3.98 Million | -9.97 Million | -11.22 Million | -13.39 Million | -2.03 Million |
| Effect of forex changes on cash | 2.07 Million | -475 Thousand | -116 Thousand | 342 Thousand | -96 Thousand | -43 Thousand |
| Net cash flow / Change in cash | -5.14 Million | 7.12 Million | -1.16 Million | 15.78 Million | -173 Thousand | -1.15 Million |
| Free Cash Flow | -63.82 Million | -89.01 Million | -109.65 Million | -96.39 Million | -69.38 Million | -35.81 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -362 Thousand | -2.05 Million | -33.76 Million | -11.92 Million | -13.23 Million | -18.34 Million |
| Depreciation & Amortization | 256 Thousand | 264 Thousand | -3.28 Million | 874 Thousand | 1.24 Million | 1.4 Million |
| Deferred income taxes | - | - | -47.94 Million | 733 Thousand | -3.26 Million | -2.04 Million |
| Stock-based compensation | 129 Thousand | 202 Thousand | -1.88 Million | 3.03 Million | 1.27 Million | 1.73 Million |
| Change in working capital | -2.99 Million | -2.91 Million | -880 Thousand | 916 Thousand | 165 Thousand | 2.4 Million |
| Other non-cash items | 205 Thousand | 87 Thousand | 69.75 Million | -57.24 Million | -197 Thousand | 269 Thousand |
| Investing Cash Flow | 4.46 Million | 9.23 Million | 11.22 Million | 58.55 Million | 16.94 Million | 15.13 Million |
| Investments in PPE | -38 Thousand | -105 Thousand | 1.17 Million | -219 Thousand | -410 Thousand | -752 Thousand |
| Acquisitions | 2.97 Million | 7.3 Million | -1.11 Million | 17 Million | - | -15.88 Million |
| Investment purchases | - | - | -1.24 Million | -39.76 Million | -4.64 Million | -5.86 Million |
| Sales/Maturities of investments | 1.5 Million | 1.75 Million | 12.5 Million | 82.75 Million | 22 Million | 21.75 Million |
| Other Investing Activities | 31 Thousand | 7.3 Million | -1.21 Million | -1.21 Million | - | 15.88 Million |
| Financing Cash Flow | -2.62 Million | -42 Thousand | -495 Thousand | -2.17 Million | -1.93 Million | -21 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 275 Thousand | -111 Thousand | -12 Thousand | -46 Thousand |
| Common Stock Issuance | - | - | -29 Thousand | 29 Thousand | - | 25 Thousand |
| Other Financing Activities | -2.62 Million | -42 Thousand | -490 Thousand | -2.2 Million | -1.92 Million | -21 Thousand |
| Accounts receivables | -1.5 Million | -819 Thousand | -2.31 Million | -1.07 Million | 1.44 Million | -193 Thousand |
| Accounts payables | -1.48 Million | 404 Thousand | 290 Thousand | 288 Thousand | -826 Thousand | -49 Thousand |
| Inventory | 675 Thousand | -1.61 Million | -83 Thousand | -2.48 Million | -57 Thousand | -733 Thousand |
| Other working capital | -684 Thousand | - | 1.23 Million | 4.18 Million | -400 Thousand | 3.38 Million |
| Cash at beginning of period | 18.45 Million | 26.2 Million | 31.11 Million | 31.34 Million | 30.05 Million | 29.87 Million |
| Cash at end of period | 13.32 Million | 18.45 Million | 26.2 Million | 26.2 Million | 31.11 Million | 30.05 Million |
| Capital Expenditure | -38 Thousand | -105 Thousand | 1.17 Million | -219 Thousand | -410 Thousand | -752 Thousand |
| Effect of forex changes on cash | -2000.00 | - | 2.37 Million | 2.07 Million | 52 Thousand | -354 Thousand |
| Net cash flow / Change in cash | -5.13 Million | -7.74 Million | -4.91 Million | -5.14 Million | 1.05 Million | 180 Thousand |
| Free Cash Flow | -7.01 Million | -17.03 Million | -16.83 Million | -63.82 Million | -14.41 Million | -15.33 Million |
BSXGF
BAYP
1439
EDSFF
STLAM
LIFE